|
🐢
|
Guidelines for the welfare and use of animals in cancer research
20 auth.
P. Workman,
E. Aboagye,
F. Balkwill,
A. Balmain,
G. Bruder,
D. Chaplin,
J. Double,
J. Everitt,
D. Farningham,
D. Farningham,
...
M. Glennie,
L. Kelland,
V. Robinson,
I. Stratford,
G. Tozer,
S. Watson,
S. Wedge,
S. Eccles,
V. Navaratnam,
S. Ryder
|
10 |
2010 |
10
🐢
|
|
🐬
|
The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development
P. Walker,
S. Ryder,
Andrea Lavado,
C. Dilworth,
R. Riley
|
5 |
2020 |
5
🐬
|
|
🐜
|
Identifying and Characterizing Stress Pathways of Concern for Consumer Safety in Next-Generation Risk Assessment
10 auth.
S. Hatherell,
M. Baltazar,
J. Reynolds,
P. Carmichael,
M. Dent,
Hequn Li,
...
S. Ryder,
A. White,
P. Walker,
A. Middleton
|
5 |
2020 |
5
🐜
|
|
🐬
|
The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development
P. Walker,
S. Ryder,
Andrea Lavado,
C. Dilworth,
R. Riley
|
0 |
2020 |
0
🐬
|
|
🐜
|
P11-07 High-content screening and high-throughput RNA sequencing using hiPSC-CMs for the assessment of functional and structural cardiotoxicity
9 auth.
A. Rosell-Hidalgo,
C. Bruhn,
E. Shardlow,
S. Ryder,
R. Barton,
M. Reis,
...
R. Fritsch,
C. Strock,
P. Walker
|
0 |
2022 |
0
🐜
|
|
🦁
|
A multiplexed in vitro approach for the dual detection of functional and structural cardiotoxicity
S. Ryder,
B. Park,
N. Stratton,
A. Smith,
S. Roe,
P. Walker
|
0 |
2021 |
0
🦁
|
|
🐜
|
Using a comprehensive in vitro approach to gain insights into mechanism of mitochondrial toxicity
7 auth.
M. Ogese,
J. Eakins,
Z. Zia,
Samantha Bevan,
A. Lazardi,
S. Ryder,
...
P. Walker
|
0 |
2021 |
0
🐜
|
